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The synthesis ofIgE is regulated by isotype-specific mechanisms. Powerful poly-
clonal B cell activators, such as PWM, Staphylococcus aureus Cowan I (SAC),' and
EBV, consistently failed to induce IgE synthesis by normal B cells (1, 2). The latter
can, however, be induced to produce IgE upon cognate interaction with selected
alloreactive or autoreactive T cellclones (3-5). Furthermore, Tcell clones activated
byanti-CD3 mAborPHAinducedB cellsto synthesizeIgEin theapparent absence
ofalloantigen recognition (6). These results indicated that normal B cell precursors
can be induced to differentiate into IgE-secreting cells by appropriate stimuli.
Ithasbeen recently shown that the T cell-derived lymphokine B cell stimulatory
factor 1 (BSF1)/IL-4plays a central role in the regulation ofIgE synthesis. In mice,
IL-4 induces polyclonal IgE and IgGI production in vitro by LPS-stimulated B cell
blasts (7, 8), and the in vivo administration of an anti-IL-4 antibody inhibits the
IgE response (9, 10). In humans, we and others have recently shown that rIL-4 in-
duces IgE synthesis by normal peripheral blood lymphocytes (11-15). Furthermore,
supernatants from T cell clones secretingIL-4 possess an IgE-inducing ability that
can be completely abolished by an anti-IL-4 antibody (12, 13, 16).
The cellular and lymphokine requirements for the IL-4-dependent induction of
IgE synthesis are quite complex. We have recently shown (17) that the induction
of IgE by human rIL-4 is strictly T cell dependent, is optimal in the presence of
monocytes, and isamplifiedbyIL-5 andIL-6. Furthermore, endogenous IL-6plays
an obligatory rolein IL-4-induced IgE synthesis, sinceanantibody to IL-6 strongly
inhibited IL-4-induced IgEproduction. However, undernoconditionoflymphokine
stimulation could purified B cells be induced to synthesizeIgE. Thus, solublesignals
delivered by recombinant lymphokines in various combinations could not replace
T cells and monocytes in theIL-4-dependent induction ofIgE synthesis. This strongly
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suggested that cell-cell interactions might also be required. In the present study,
we show that cognate T/B cell recognition via MHC class II antigens and the
TCR/CD3 complex is necessary for IL-4-dependent IgE synthesis to proceed. Ac-
cessory adhesion molecules expressed on B and/or T cells also contribute to the cel-
lular interactions required for IgE synthesis.
Materials and Methods
Interleukins andAntibodies.
￿
Human rIL-4 was used in a purified form (specific activity:
1.2 x 107 U/mg). Human rIL-6 (specific activity: 5 x 106 U/mg) was a kind gift of T. Kishi-
moto and T. Hirano (Osaka University, Osaka, Japan). mAb TS1/22, amurine IgGI specific
forthea chain of the LFA-1 molecule, was a kind gift ofDrs. StevenJ. Burakoff and Barbara
E. Bierer (Harvard MedicalSchool, Boston, MA). Anti-HLA-DR(clone L243, IgG2a specific
foranonpolymorphic HLA-DR epitope), anti-Leu-5b (IgG2a anti-CD2), anti-Leu-4 (IgGl
anti-CD3), anti-Leu-3a (IgGI anti-CD4), anti-Leu-2a (IgGl anti-CD8), anti-Leu-9 (IgG2a
anti-CD7), anti-Leu-M3 (IgG2b anti-CD14), TCR-1 (WT31, an IgGI mAb specific for a
framework determinant of the TCRa/,Q heterodimer) mAbs, as well as the appropriate iso-
type controls, were obtained from Becton Dickinson & Co. (Mountain View, CA). OKT3
(IgG2a anti-CD3) andOKIal (IgG2 anti-HLA-DR) mAbs were obtained from OrthoDiag-
nostic Systems Inc. (Westwood, MA). mAb BI (IgG2a anti-CD20) andW6-32 (IgG2a anti-
MHC class I) were obtained from Coulter Immunology (Hialeah, FL) andAmerican Type
Culture Collection (Rockville, MD), respectively. A polyclonal rabbit antibody to IL-4 was
a kind gift of Dr. J. de Vries (UNICET, Dardilly, France).
Preparation of TCell Clones.
￿
TT andalloantigen-specific helper Tcell clones were obtained
by limiting dilution as previously described (3, 18, 19). Briefly, PBMC suspended in RPMI
1640 (M. A. Bioproducts, Walkersville, MD) and 10% AB' serum (Hazleton Research Prod-
ucts, Lenexa, KA) were stimulated with TT or irradiated allogeneic PBMC for 6 d and the
blasts were enriched by centrifugation over adiscontinuous Percoll (Pharmacia Fine Chem-
icals, Piscataway, NJ) gradient. Cells at the 30-50% interface were then cultured at limiting
dilutions(0.3 cells/well) in 96-wellplates in thepresence of irradiated autologous PBMC plus
TT, and IL-2-containing supernatants. The CD3', CD4', 4134', CD8- T cell clones thus
obtained have been maintained in long-termculture by repeated addition of irradiated autol-
ogous PBMC plus TT, or irradiated allogeneic PBMC and IL-2-containing supernatants.
Cell Preparations.
￿
PBMC were isolated from heparinized venous bloodof normal nonallergic
donors by density gradient centrifugation on Ficoll-Hypaque, washed three times in HBSS
(Microbiological Associates, Bethesda, MD) and resuspended in RPMI 1640/10% heat-
inactivated FCS(HyClone Laboratories, Logan, UT) supplemented with 2 MM L-glutamine,
50 Fcg/ml streptomycin and 100 U/ml penicillin (complete medium). To obtain purified B
cells, Tcellswere removed by rosettingtwicewith 2-aminoethylisothiouronium bromide(AET)-
treated SRBC . Further T cell depletion was obtained by two cycles of lysis with anti-CD3
mAb + rabbit C (Pel-Freeze Biologicals, Inc., Rogers, AR). To remove monocytes, non-T
cells in RPMI 1640/10% AB' serum were adhered twice in plastic petri dishes. The resulting
B cell populations contained <6% CD14' cells and <1% CD3' cells, as determined by im-
munofluorescence (IF). In addition, these B cell preparations gave no proliferative response
to Con A or PHA (10 ug/ml), while they strongly proliferated upon stimulation with PMA
(25 ng/ml; Sigma Chemical Co., St. Louis, MO) and insolubilized anti-k antibody (Im-
munobead rabbit anti-human IgM; 1 Ftg/ml; Bio-Rad Laboratories, Richmond, CA). Cell
viability, as assessed by trypan blue exclusion, was always >95%.
T cells were purified by rosetting twice with AETSRBC. The SRBC were then removed
by NH4C1 lysis and the cells were resuspended in RPMI 1640/10% AB' serum and adhered
twice in plastic petri dishes. The nonadherent cells thus obtained contained >97o7o CD3'
cells, as detected by IF.
Cell Cultures for IgE Induction.
￿
Unfractionated PBMC or purified B cells (1 .5 x 106
cells/ml) in complete medium were cultured at 37°C in a 5% COZ humidified atmosphere,
in the presence of rIL-4 (100 U/ml) and the various mAbs, as indicated for each experimentin Results. In some experiments, purified B cells were incubated with supernatants from cul-
tures of T cells or T+B cells (1.5 x 106 cells/ml, 2:1 ratio) stimulated for 48 h with rIL-4
(100 U/ml). Insolubilized anti-A antibodies (1-10 pg/ml) or SAC (0.1% ; The Enzyme Center
Inc., Malden, MA) were added to cultures of purified B cells in other experiments. Autolo-
gous T/B cell mixtures (1.5 x 106 cells/ml) were cultured under the same conditions. In some
experiments, autologous purified T and B cells were separated during culture by a 0.4 Am
membrane using well inserts (Millicell-HA, Millipore Corp., Bedford, MA). After 9 d, the
culture supernatants were harvested and assessed by RIA for their IgE content. Control cul-
tures for the evaluation of preformed IgE were set up in the presence of cycloheximide (100
Wg/ml; SigmaChemical Co.). Net IgE synthesis was evaluated by subtracting the IgE concen-
trations detected in cycloheximide-treated cultures from the IgE values found in untreated
cultures.
In some experiments, purified B cells (106/ml) from selected donors were cultured for 10
d with autologous monocytes (2 x 105/ml) and irradiated (2,500 rad), cloned T cells (0.4
x 106/ml), in the presence or absence of exogenous IL-4 (100 U/ml). Control cultures were
set up with cycloheximide. Culture supernatants were then harvested and assessed by RIA
for their IgE content.
RIAfor IgE.
￿
The assay was performed in flexible flat-bottomed microtiter plates (Cooke
Laboratory Products, Alexandria, VA) at room temperature as previously described (3). The
wells were coated with 0.1 ml of a 1 :1 mixture of purified anti-Fce mAbs (7.12 and 4.15; a
kind gift of A. Saxon, University of California Los Angeles, Los Angeles, CA), 2 Feg/ml in
carbonate-bicarbonate buffer, pH 9.6. After a 16-h incubation, the wells were washed, blocked
with PBS/10 % horse serum (HS) for 2 h, and subsequently washed three times with PBS/1 %
HS. 0.1 ml of culture supernatant or different dilutions of IgE standard (Pharmacia Fine
Chemicals) were then added to the wells in triplicate and incubated for 16 h in a humidified
chamber. The wells were then washed one time with PBS/1% HS containing 0.05% Tween
20, twice with PBStl% HS, and finally incubated with 0.1 ml of Phadebas RAST
1251-anti-human IgE (ND) (Pharmacia Fine Chemicals) for 6 h. The wells were then washed
three times with PBS/1% HS/0.05% Tween 20, eight times under running distilled water,
cut out, and counted in a gamma spectrometer (Tracor Analytic, Elk Grove Village, IL).
The concentrations of IgE in the supernatants were read from the standard curve. The lower
limit ofsensitivity of this assay is 150 pg/ml. This assay was validated in a recent multicenter
collaborative assessment ofthe variability ofIgE measurement in cell culture supernatants (20).
Results
Requirementsfor Cellular Interactions in IL-4-dependent IgE Synthesis.
￿
Fig. 1 shows a
dose-response curve for the effect of HL-4 on IgE synthesis by human PBMC. We
have recently shown that IL-4-induced IgE synthesis is T cell dependent and op-
E
E
N
W
VERCELLI ET AL.
￿
1297
FIGURF: 1
￿
Dose-response curve forthe
effect of rIL-4 on IgE synthesis by hu-
man PBMC. Different concentrations
of purified human rIL-4 were added to
normal PBMC (1.5 x 106 cells/ml).
After 9 d the culture supernatants were
harvested and assessed by RIA for their
IgE content. The data represent the
mean ± SE of three experiments.1298
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timal in the presence of monocytes. IL-5 and IL-6 strongly amplify IgE synthesis.
More importantly, endogenous IL-6is required forIL-4-induced IgE synthesis (17).
TableIshowsthat acombination oftheselymphokinescould notinduce IgE production
by highly purified B cells, even in the presence of powerful polyclonal B cell acti-
vators, such as insolubilized anti-g antibodies and SAC. B cells, however, became
responsive to IL-4 upon readditionofTcells. Infive experimentswithdifferent normal
donors, the B/T cell ratio required for substantial induction ofIgE synthesis ranged
from 10:1 to 1:2. The addition of T cells at a 1:4 B/T cell ratio consistently sup-
pressed IL-4-dependent IgE synthesis (data not shown). These results indicate that
soluble signals cannot replace T cells in the IL-4-dependent induction ofIgE syn-
thesis. Furthermore, purified normal B cells did not produce IgE in response to su-
pernatants from T cells or T/B cell mixtures incubated for 48 h in the presence of
IL-4 (100 U/ml) (data not shown). This ruled out the possibility that the induction
of IgE synthesis by purified B cells requires unidentified labile short-range medi-
ator(s) released by the T and/or B cells upon IL-4 stimulation.
Taken together, these data indicated that the requirement for T cells could not
be bypassed by soluble T cell products and suggested that physical interactions be-
tweenT andB cellsmight be required forIgE synthesis. This hypothesis was further
supported by experiments in which autologous purified T and B cells were cultured
in the presenceofrIL-4 (100 U/ml), either in the same well or separated by a 0.4-Ftm
membrane permeable to protein macromolecules. As shown in Table II, vigorous
IgE synthesis was only induced in the cultures in which T and B cells were allowed
to come in contact. These data indicate that disruption of cell-cell contact results
in the inhibition of the IgE-inducing activity of IL-4.
IL-4 DependentIgESynthesis is Inhibitedby nzAbsSpecificforCell Adhesion Molecules. A
numberofsurfacemoleculeshavebeen recentlycharacterized which enhance antigen-
independent adhesion between T cells and APCs ortarget cells, and stabilizecell-cell
contacts. These structures are collectively known as cell adhesion molecules (CAMs)
(21, 22). Since the previous experiments had indicated that IL-4 induced IgE syn-
Cell populations
TABLE I
IL-4 and IL-6 Do Not Induce IgE Synthesis by Highly Purified B Cells
PBMC, unfractionated
Purified B cells, unstimulated
+ anti-14 antibody
+ SAC
+ T cells (1 :2 ratio)
Net IgE synthesis
+ medium
￿
+ rIL-4 + rIL6
pglml
<150
￿
4,350
<150
￿
230
<150
￿
200
<150
￿
230
390
￿
3,410
Cell populations (PBMC, purified B cells, or reconstituted autologous T/B cell mixtures: 1 .5
x 106 cells/ml) from normal donors were incubated with medium or rIL-4 + rIL-6 (100
U/ml). Purified B cells were stimulated with insolubilized anti-,u antibody (1-10 Wg/ml) or SAC
(0.1 %). Culture supernatants were harvested after 9 d and assessed by RIA for their IgE con-
centration. Control cultures were set up in the presence of cycloheximide (100 lag/ml). Net
IgE synthesis was determined by subtracting IgE concentrations in cycloheximide-treated cul-
tures from IgE concentrations in untreated cultures.VERCELLI ET AL.
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TABLE II
Physical Separation ofB from T Cells Prevents IgE Synthesis
B cells (0.6 x 106 cells/culture) from normal donors in complete medium were
cultured in 0.7 ml wells. T cells (1 .2 x 106 cells/culture) were cultured either
in wells with the B cells or in inserts, separated from B cells by a 0.4-pm mem-
brane. rIL-4 was added at 100 U/ml. After 9 d the supernatants from wells and
inserts were separately harvested and assessed for their IgE content. Net IgE
synthesis was evaluated as described in the legend to Table I .
thesis requires physical T-B cell interactions, we next asked whether CAMS play
a role in such interactions. To this purpose, PBMC from normal donors were in-
cubated with optimal concentrations of rIL-4 (100 U/ml) in the presence of mAbs
specific for various CAMS expressed by B cells and/or T cells. As shown in Table
III, anti-CD2 and anti-CD4 mAbs strongly and consistently inhibited IL-4-induced
IgE synthesis. Anti-LFA-1 (a chain) mAb had a more variable effect, although in
most experiments it inhibited IL-4-induced IgE synthesis. By contrast, no inhibi-
tion was observed using anti-CD8 mAb or the pan-T anti-CD7 mAb.
These resultssuggested that CAMS play an important role in the cellular interac-
tions required for IL-4-dependent IgE synthesis.
rnAbsSpecificforthe TCR/CD3 ComplexandMHC Class IIAntigens Inhibit IL-4-induced
IgE Synthesis. We next asked whether the TCR/CD3 complex also plays a role in
T/B cell interactions required for IL-4-induced IgE synthesis. To this purpose, we
TABLE III
Anti-CAM mAbs Inhibit IgE Synthesis Induced by rIL-4
Unfractionated normal PBMC (1.5 x 106 cells/ml) were cultured with rIL-4 (100
U/ml), in the presence or absence of mAbs to LFA-1 (IOpg/ml), CD2 (1 Wg/ml),
CD4 (2.5 Kg/ml, CD8 (1 jug/ml), CD7 (3 lug/ml). After 9 d the culture superna-
tants were harvested and assessed by RIA for their IgE content . Net IgE syn-
thesis was evaluated as described in the legend to Table I . The mAbs bythemselves
had no effect on IgE synthesis.
Stimulus mAb Exp. 1
Net IgE synthesis
Exp. 2
pg1ml
Exp. 3
Nil - <130 <150 <150
rIL-4 - 20,300 2,700 8,200
rIL-4 Anti-LFA-1 8,900 2,600 150
rIL-4 Anti-CD2 300 <150 <150
rIL-4 Anti-CD4 4,850 650 1,600
rIL-4 Anti-CD8 22,000 4,000 9,400
rIL-4 Anti-CD7 19,300 3,100 9,000
Culture Cells
Net
Exp. 1
IgE synthesis
Exp. 2
pg/ml
Well: B + rIL-4 <150 <150
Insert: T + rIL-4 <150 <150
Well: B + T + rIL-4 11,000 1,5001300
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TABLE IV
mAbs to the TCR/CD3 Complex Inhibit IgE Synthesis Induced by rIL-4
Unfractionated normal PBMC (1.5 x 106 cells/ml) were cultured with rIL-4 (100
U/ml), in the presence or absence ofanti-CD3 (0.1 14g/ml), anti-Leu-4 (I jig/ml),
or WT-31 (1 Ftg/ml) mAbs. After 9 d the culture supernatants were harvested
and assessed by RIA for their IgE content. Net IgE synthesis was evaluated as
described in the legend to Table I.
studied the effect ofanti-CD3 mAbs on IgE production inducedby rIL-4 innormal
PBMC. Both OKT3 and anti-Leu-4 inhibited IL-4-dependent IgE synthesis(Table
IV, Exps. 1 and 2), although they induced a strong proliferative response (data not
shown). Inhibition of IgE synthesis by anti-Leu-4 was also observed in the virtual
absence ofproliferation usingPBMC from a"Leu-4 nonresponder" (23) whose mono-
cytes do not express Fc receptors for mouse IgG1 (Table IV, Exp. 3). Thus, anti-
CD3 mAbsinhibited IL-4-induced IgE synthesisbyPBMC regardless oftheir effect
on cell proliferation. Furthermore, IgE synthesis was inhibited by WT31, a mAb
specific for a framework determinant ofthe TCR-a//3 heterodimer (24), which also
induced strong cell proliferation (data not shown) .
In parallel, we assessed the role of MHC class II antigens in cell interactions re-
quired for IL-4-induced IgE synthesis. As shown in Table V, anti MHC class II
(HLA-DR) mAb (L243) completely inhibited IgE synthesis induced by rIL-4 (100
TABLE V
Anti-MHC Class II (HLA-DR) mAb Inhibits IgE Synthesis
Induced by rIL-4 f rIL-6
Unfractionated normal PBMC (1.5 x 106 cells/ml) were cultured with rIL-4 (100
U/ml) t rIL-6 (100 U/ml), in the presence or absence of anti-MHC class II
(HLA-DR: 2.5 Wg/ml), anti-MHC class I (1 tag/ml), or anti-CD20 (1 tag/ml)
mAbs. After 9 d the culture supernatants were harvested and assessed by RIA
for their IgE content. Net IgE synthesis was evaluated as described in the legend
to Table I.
Stimulus mAb
Net
Exp. 1
IgE synthesis
Exp. 2 Exp. 3
pglml
Nil - <150 <150 <150
rIL-4 - 16,200 2,500 2,200
rIL-4 Anti-MHC class II <150 <150 <150
rIL-4 Anti-MHC class I 13,800 3,950 2,500
rIL-4 Anti-CD20 17,000 2,200 ND
rIL-4 + rIL-6 - 57,000 18,500 9,900
rIL-4 + rIL-6 Anti MHC class II <150 250 <150
Stimulus mAb Exp. 1
Net IgE synthesis
Exp. 2 Exp. 3
pg/ml
Nil - <150 <150 <150
rIL-4 - 5,900 2,450 1,750
rIL-4 Anti-CD3 850 <150 550
rIL-4 Anti-Leu-4 ND <150 300
rIL-4 WT-31 <150 ND <150U/ml). Comparable results were obtained using an anti-HLA-DR mAb (OKIal)
from adifferent source (data not shown). By contrast, mAb specific for MHC class
I antigens or the pan-B cell antigen CD20 had no effect . Furthermore, anti-HLA-
DR mAb strongly inhibited high-rate IgE synthesis induced by a combination of
IL-4+IL-6. Interestingly, anti-HLA-DR mAb inhibited PBMC proliferation induced
by rIL-4, but not by rIL-2 (data not shown). This suggests that inhibition by anti-
HLA-DR mAb did not result from cell toxicity.
These results show that thecellular interactions required for IL-4-dependent IgE
synthesis are mediated by the TCR/CD3 complex on T cells and MHC class II
antigens on B cells, and suggest that cognate T/B cell interactions may be involved
in IL-4-driven induction of IgE synthesis.
Cognate T/B Cell Interaction Is Requiredfor IL-4-dependent IgE Synthesis.
￿
Although
the results ofthe previous experiments strongly pointed at a role of cognate T/B
cell interactions in IL-4-dependent IgE synthesis, we had toconsiderthepossibility
that inhibition of IgE production by mAbs to CAMS, MHC class II antigens, and
TCR/CD3 complex may result from direct negative signaling to the T and/or B
cells. We therefore examined the requirement for T/B cell interactions for IgE in-
duction by alloreactive human T cell clones. To this purpose, we compared the IgE
inducing ability of two human IL-4-producing alloreactive T cell clones, F6 and
Al, which have different MHC recognition properties.
CloneF6is aTTspecific T cellclone, which also recognizes HLA-DR4andproduces
IL-4, as well as IL-2 and IFN-7 (3, 19). As shown in Table VI, clone F6 strongly
VERCELLI ET AL.
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TABLE VI
Cognate TIB Cell Interaction Is Requiredfor IL-4-dependent IgE Synthesis
Purified B cells (106/ml) from selected normal donors were cultured for 10 d with autolo-
gous monocytes (2 x 105/ml) and irradiated (2,500 rad), cloned T cells (0.4 x 106/ml), in
the presence or absence ofexogenous IL-4 (100 U/ml). A polyclonal anti-IL-4 antibody was
added at 1 :500. Control cultures were set up with cycloheximide. Culture supernatants were
then harvested and assessed by RIA for their IgE content. Net IgE synthesis was evaluated
as described in the legend to Table I. Tissue typing of the B cell donors was kindly performed
by the HLA laboratory at the Dana Farber Cancer Institute, Boston, MA. Clone F6 and
Al showed intense proliferation upon incubation with B cells from donor DL (HLA-DR4* ),
but not with cells from donor RC (HLA-DR5').
Clone Al recognizes an HLA-DP-associated epitope on monocytes, but not on B cells (26).
B cell donor Cognate interaction Clone HL-4 Net IgE synthesis
pglmt
DL Yes - - <150
- + <150
F6 - 20,500
F6 - + anti-IL4 600
F6 + 23,000
RC No - - <150
- + <130
F6 - 500
F6 + <150
DL Yes* - - <150
- + <150
Al - <150
Al + <1501302
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induced IgE synthesis by purified normal B cells from an HLA-DR4+ allostimu-
lator (DL). IgE production was not further significantly increased by the addition
ofexogenous IL-4, but was IL-4 dependent, since it was blocked by an anti-IL-4
antibody. By contrast, clone F6 did not induce IgE synthesis from HLA-DR5+ al-
logeneic B cells (RC) or from HLA-DR3, 5+ autologous B cells (SA; data not
shown). Exogenous IL-4 at high concentrations (100 U/ml) could not restore the
IgE-inducing ability of clone F6 in the latter cultures, while it induced a vigorous
IgE response by PBMC from all three B cell donors (data not shown). Thus, the
failure ofclone F6 to induce IgE production by B cells lacking the relevant alloan-
tigenwas notdueto theabsenceofcirculatingB cellspotentially able todifferentiate
into IgE production, nor to the absence of IL-4.
Clone A1 is the human equivalent ofa murine Th2 clone, in that it secretes IL-4
but not IL-2 or IFN-y (19). Supernatants from clone A1 induce IgE synthesis by
normal PBMC and FcrzR2/CD23 expression on monocytes. Both effects are IL-4
dependent, since they can be inhibited by an anti-IL-4 antibody (12, 25). Interest-
ingly, clone A1 recognizes an HLA-DP-associated antigen expressed on monocytes,
but not on B cells (26). We therefore incubated clone A1 with monocytes (as stimu-
lator cells) and B cells (as bystander effector cells) from a donor (DL) bearing the
appropriate alloantigen. As shown in Table VI, clone A1 did not induce IgE syn-
thesis, although under such conditions the clone strongly proliferates and secretes
large amounts ofIL-4 (19, 26). Furthermore, addition ofexogenous IL-4tocultures
ofcloneA1 and B cellsfromdonor DL did notresult inIgE synthesis. As mentioned
above, PBMC from donor DL vigorously synthesized IgE upon stimulation with
rIL-4, and B cells from the same donor were induced to synthesize IgE in the pres-
ence of clone F6. These results conclusively show that the signal delivered by IL-4
is not sufficient to induce B cells to synthesize IgE; cognate T/B cell recognition is
necessary, as well.
Discussion
We have recently shown that the induction of IgE synthesis by IL-4 requires T
cells and monocytes, as well as T cell- and monocyte-derived cytokines (17). Op-
timal cytokine combinations, however, fail to induce highly purified B cells to se-
crete IgE, indicating that additional signals are necessary. Our results now show
that IL-4-dependent IgE synthesis by circulating B cells requires cognate interac-
tion between the TCR/CD3 complex on T cells and MHC class II antigens on B
cells, as well as the contribution of cell adhesion molecules, as determined by the
ability ofmAbs directed against these structures to block IgE synthesis induced by
IL-4, and by the MHC class II-restricted IgE-inducing ability of IL-4-producing
alloreactive T cell clones. The observation that anti-MHC class II, but not anti-
MHC class I, mAbs inhibited IL-4-dependent IgE synthesis is consistent with the
finding that anti-CD4 mAb, but not anti-CD8 mAb, blocked IgE production, and
indicates that a CD4+ helper T cell subset is involved in B cell recognition. In fu-
ture experiments we will attempt a further phenotypic and functional characteriza-
tion ofthe T cell population(s) involved in the T cell-dependent induction of IgE
synthesis.
We considered the possibility that inhibition of IL-4-induced IgE synthesis by
the various antibodies used in this study resulted from direct negative signaling toVERCELLI ET AL.
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the B and/or T cells, rather than from interference with T/B cell recognition. Anti-
HLA-DR mAbs, including L243, are known to directly inhibit B cell activation,
particularly in its early steps (27, 28). At the T cell level, antibodies to CD2, CD4,
and LFA-1 can inhibit signal transduction, thus blocking T cell functions (29-32).
It is, however, unlikely that the inhibition of IgE synthesis results from direct nega-
tive signals to the T and/or B cells, because inhibition of IgE synthesis by antiTCR
and anti-CD3 mAbs occurred in spite ofthe induction ofvigorous T cell proliferation.
To completely rule out the negative-signal hypothesis, we used an experimental
system in which normal B cells are stimulated to produce IgE by IL-4-producing
alloreactive T cell clones. Such a system, in which no external stimuli can deliver
direct negative signals to the T and/or B cells, is only constrained by T/B cell recog-
nition. Clone F6, which recognizes MHC class Il antigens expressed on both B cells
and monocytes (26), induced IL-4-dependent IgE synthesis in B cells bearing the
relevant alloantigen, but not in HLA-mismatched B cells. By contrast, clone Al,
which recognizes MHC class II antigens only on monocytes (26), did not induce
IgE synthesis when incubated with HLA-matched B cells and monocytes, in spite
of a strong proliferative and lymphokine response. A comparison of the results ob-
tained with clone Al and F6 suggests that the failure of clone Al to induce IgE syn-
thesis is likely to result from the lack of direct T/B cell recognition. Previous studies
with clone F6 (3) and with clone Al (19) indicated that bystander B cells are induced
to synthesize IgG in cultures containing the cloned T cells and monocytes bearing
the stimulator alloantigen. This indicates that the requirements for the synthesis
of these two isotypes are not identical.
Interestingly, clone F6 induced IgE synthesis by B cells in spite of its ability to
secrete high amounts of IFN-y. These results are in apparent contrast with previous
reports describing the inhibitory effect on human IgE production by IFN-y con-
tained in the supernatant of alloreactive T cell clones producing both IFN-y and
IL-4 (13, 16). In those reports, however, the responding B cells were not engaged
in direct cognate interaction with the T cell clones. Since cognate interaction has
been shown to play a crucial role in focusing the release ofT cell-derived lymphokines
(and in particular, IL-4) at the area in which the TCR is crosslinked by the antigen
(33, 34), direct T/B cell recognition, in the presence ofendogenously secreted IL-4,
may deliver to the B cells an activating signal sufficient (and necessary) to bypass
the inhibitory effect of IFN-y. Furthermore, experiments in the murine system (in
which IL-4 typically induces IgE and IgG1 [7]) have shown that the addition of IL-4
to cultures containing a TNP-specific Thl clone (producing IFN-'v but not IL-4)
resulted in the production of IgG1 antiTNP by TNP-specific B cells (35). These
data indicate that IL-4 responsiveness can be retained in the presence of IFN-y in
systems that involve T/B cognate interaction.
Taken together, our results suggest that at least two signals are involved in the
T cell-dependent triggering of IgE production by B cells: one signal is delivered
by T cells recognizing MHC class II antigens on B cells, the other by T cell-derived
IL-4. These two signals are likely to synergize in the activation of B cells into IgE
production. IL-4 stimulation ofB cells, which bear IL-4 receptors even in their resting
state (36, 37), increases MHC class II antigens density by 5- to 10-fold (38). An
increased density of MHC class II antigens on B cells may enhance their capacity
to activate a subset ofT cells recognizing autologous MHC class II antigens + self1304
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peptides (5, 39), or + foreign peptides. In our experimental system, foreign pep-
tides may be derived from the bovine serum. The interaction between TCR and
their targets described here seems to have a low affinity, since it is critically depen-
dent on accessory molecules (40).
Thus IL-4 would, on the one hand enhance T/B cognate recognition, and on the
other hand, drive the B cell response towards the IgE isotype, acting as an IgE-switching
factor (41-43). IfT/B cell recognition in the presence of IL-4 is necessary and sufficient
to induce IgE synthesis, we would predict that IL-4-dependent IgE production should
occur also in allogeneic T/B cell mixtures, as a result of the activation of a subset
of T cells able to recognize MHC class II antigens expressed on the allogeneic B
cells. Experiments currently in progress in our laboratory indicate that this is in-
deed the case (Vercelli, D., H. H. Jabara, and R. S. Geha, unpublished observation).
Summary
The induction of IgE synthesis by IL-4 requires T cells and monocytes, as well
as T cell- and monocyte-derived cytokines . Optimal cytokine combinations, how-
ever, fail to induce highly purified B cells to secrete IgE, indicating that additional
signals are required. We show herein that the induction of human IgE synthesis
by rIL-4 requires cognate interaction between the T cell receptor/CD3 complex on
T cells and MHC class 11 antigens on B cells: mAbs directed against these molecules
completely blocked IL-4-dependent IgE induction. mAbs against cell adhesion mol-
ecules (CD2, CD4, LFA-1) also inhibited IgE synthesis induced by IL-4, confirming
that cell-cell contact is necessary for IgE induction. The requirement for cognate
T/B cell interaction was further shownby comparing the IgE-inducing ability of two
human IL-4-producing alloreactive T cell clones: F6, which recognizes MHC class
II antigens on both B cells and monocytes, and Al, which recognizes an HLA-DP-
associated epitope expressed on monocytes, but not on B cells. When incubated with
B cells and monocytes from a normal donor bearing the appropriate alloantigen,
clone F6, but not clone Al, induced vigorous IgE synthesis, although both clones
proliferated and secreted IL-4 . Taken together, our results suggest that at least two,
possibly synergizing, signals are required for the T cell-dependent induction of IgE
synthesis by B cells: one signal is delivered by cognate T/B cell interaction, the other
by T cell-derived IL-4.
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